The Hungarian pharmaceutical group created a Global Corporate Services Controlling Manager position with end-to-end responsibility for planning, budgeting, reporting and analysis of Richter’s GBS cost base.
Richter puts that GBS cost base at approximately HUF100 billion (2024 figure). This provides unusually good visibility into the scale of the organisation.